Donghee Lee
Articles
-
1 month ago |
science.org | Donghee Lee |Chana F. Kranzler |Daniel Francois |Yushuo Xiao |Zhijian Tong |Chen Wang | +17 more
AbstractAcute kidney injury (AKI) has high incidence and mortality rates. Present treatments are mostly symptomatic and cause side effects due to systemic distribution; thus, targeted kidney drug delivery is desired. Transmembrane kidney injury molecule-1 (KIM1) is expressed at low levels in normal kidneys but markedly up-regulated following injury, making it an ideal marker/target for injured kidneys.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →